Healthcare & Pharmaceutical Industry Analysis

With analytical modeling and forecasting capabilities spanning more than 60 countries, most of the industry's manufacturers, and thousands of drugs, our Healthcare and Pharmaceutical Industry practice gives you comprehensive coverage of global healthcare and pharmaceutical markets.

We provide an independent, comprehensive range of analysis, forecasts, data and consulting services for:
- Pharmaceutical manufacturers
- Wholesalers
- Distributors
- Insurance companies
- Government agencies
- Research firms
- Healthcare providers
- Policymakers
From daily online analysis of the latest healthcare and pharmaceutical news to detailed special reports and databases, our services can help you:
- Evaluate market opportunities and risks
- Monitor competitors and customers
- Make informed decisions
- Assess the impact of a changing regulatory environment
- Plan and forecast budgets
- Stay up to date with recent industry developments and market trends

World Markets Analysis
Our range of World Markets Analysis products provide online news analysis, detailed special reports, forecasts and data access tools covering global healthcare markets, specific therapeutic areas, generics and biosimilars and pricing and reimbursement:

World Markets Healthcare
Online daily analysis of global healthcare news, special reports and extensive datasets on nearly 70 countries, 40 companies and more than 1,200 approved drugs.

World Markets Healthcare Forecasting Service
History and forecasts of healthcare expenditure and pharmaceutical sales for nearly 40 countries. These rigorous econometric forecasts quantify spending and sales for approximately 20 concepts.

World Markets Generics and Biosimilars
Online daily analysis of generics and biosimilars news, plus special reports and country reports covering more than 60 pharmaceutical markets and every single generic drug approved since 2003 in the top five EU countries and the United States.

World Markets Pricing and Reimbursement
Online daily analysis of Pricing and Reimbursement news, and detailed profiles covering over 25 markets, plus a P&R database of guideline differences in over 30 markets.

World Markets Therapeutic Suite

Online daily analysis of news, disease profiles, drug classes and regulatory topics and a pricing and clinical database for the Oncology, Ophthalmology and Cardiovascular therapeutic areas:

IHS healthcare multi-client studies (MCS) provide unique, in-depth insight into the key questions and challenges facing the healthcare industry.

These studies employ a qualitative approach, including over 50 interviews per report conducted by local analysts with healthcare stakeholders from each country. They are enhanced by our healthcare and pharmaceutical team of experts and resources, providing a solid basis for analysis and forecasts.

Our reports, covering policy, pricing, devices and more are fully customizable, and we encourage clients to validate and modify the scope and interview guidelines to accommodate specific business needs.

Find out more about our Multi-client Studies and Market Research

World Markets Healthcare Forecasting Service
History and forecasts of healthcare expenditure and pharmaceutical sales for 40 countries. These rigorous econometric forecasts quantify spending and sales for approximately 20 concepts.

Pharma Risk-Sharing Agreement Services
Extensive data, research and analysis for pharmaceutical companies interested in risk-sharing agreements for launching new drugs. Used by pharmaceutical pricing and reimbursement specialists to weigh the pros and cons of risk sharing.

PharmOnline International
Instant access to global pricing and reimbursement strategies at the click of your mouse. Immediate comparisons of pricing and reimbursement levels for all approved branded and generic drugs, as well as insight into therapeutic areas and company portfolios.

US Healthcare Cost Service
Used by hospitals, physician services, nursing homes and health facilities, the US Healthcare Cost Service provides analysis and forecasts of key input costs for US healthcare facilities, including nursing wages, drugs and utilities. Our team of industry experts analyzes current cost patterns, projects future changes in prices and wages and reports on the economic assumptions underlying the forecasts.